本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ORTHOCELL LTD

1.325
-0.015-1.12%
成交量:86.57萬
成交額:117.05萬
市值:3.21億
市盈率:-83.13
高:1.395
開:1.375
低:1.315
收:1.340
資料載入中...

公司資料

公司名字:
ORTHOCELL LTD
交易所:
ASX
成立時間:
2006
員工人數:
- -
公司地址:
Building 191,Murdoch University,90 South Street,Murdoch,Western Australia,Australia
郵編:
6150
傳真:
61 8 9360 2899
簡介:
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and related technologies for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, an autologous tenocyte implantation for chronic treatment degenerative tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.